Combined hormonal contraception and the risk of venous thromboembolism: a guideline

Samantha Pfeifer, Samantha Butts, Daniel Dumesic, Gregory Fossum, Clarisa Gracia, Andrew La Barbera, Jennifer Mersereau, Randall Odem, Alan Penzias, Margareta Pisarska, Robert Rebar, Richard Reindollar, Mitchell Rosen, Jay Sandlow, Rebecca Sokol, Michael Vernon, Eric Widra

Research output: Contribution to journalArticle

36 Scopus citations

Abstract

While venous thromboembolism (VTE) is rare in young women of reproductive age, combined oral contraceptives increase the risk of VTE. In the patient in whom combined hormonal contraception is appropriate, it is reasonable to use any currently available preparation.

Original languageEnglish
Pages (from-to)43-51
Number of pages9
JournalFertility and Sterility
Volume107
Issue number1
DOIs
StatePublished - Jan 1 2017

Fingerprint Dive into the research topics of 'Combined hormonal contraception and the risk of venous thromboembolism: a guideline'. Together they form a unique fingerprint.

  • Cite this

    Pfeifer, S., Butts, S., Dumesic, D., Fossum, G., Gracia, C., La Barbera, A., Mersereau, J., Odem, R., Penzias, A., Pisarska, M., Rebar, R., Reindollar, R., Rosen, M., Sandlow, J., Sokol, R., Vernon, M., & Widra, E. (2017). Combined hormonal contraception and the risk of venous thromboembolism: a guideline. Fertility and Sterility, 107(1), 43-51. https://doi.org/10.1016/j.fertnstert.2016.09.027